S
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
Price:
4.47
HKD
6.18%
Market Closed
Market Cap:
HK$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
|
CN |
Balance Sheet
Balance Sheet Decomposition
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Balance Sheet Decomposition is not available for
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Balance Sheet
Shanghai Bio-heart Biological Technology Co Ltd
Shanghai Bio-heart Biological Technology Co Ltd
Currency: CNY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
21
|
454
|
709
|
451
|
739
|
202
|
|
| Cash |
0
|
0
|
709
|
451
|
369
|
202
|
|
| Cash Equivalents |
21
|
454
|
0
|
0
|
369
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
2
|
9
|
6
|
6
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
4
|
18
|
|
| Other Current Assets |
11
|
15
|
39
|
84
|
29
|
78
|
|
| Total Current Assets |
33
|
471
|
757
|
542
|
408
|
299
|
|
| PP&E Net |
21
|
20
|
72
|
76
|
31
|
52
|
|
| PP&E Gross |
21
|
20
|
72
|
76
|
31
|
52
|
|
| Accumulated Depreciation |
13
|
26
|
34
|
49
|
45
|
39
|
|
| Intangible Assets |
0
|
137
|
137
|
138
|
138
|
138
|
|
| Goodwill |
0
|
145
|
145
|
145
|
145
|
145
|
|
| Note Receivable |
0
|
0
|
1
|
2
|
8
|
20
|
|
| Long-Term Investments |
0
|
0
|
0
|
73
|
87
|
54
|
|
| Other Long-Term Assets |
0
|
12
|
4
|
6
|
1
|
27
|
|
| Other Assets |
0
|
145
|
145
|
145
|
145
|
145
|
|
| Total Assets |
54
N/A
|
785
+1 351%
|
1 115
+42%
|
982
-12%
|
818
-17%
|
734
-10%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
21
|
15
|
14
|
17
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
7
|
8
|
2
|
1
|
|
| Other Current Liabilities |
8
|
13
|
9
|
6
|
4
|
1
|
|
| Total Current Liabilities |
9
|
14
|
37
|
29
|
20
|
20
|
|
| Long-Term Debt |
0
|
0
|
15
|
10
|
0
|
7
|
|
| Deferred Income Tax |
0
|
21
|
21
|
21
|
21
|
21
|
|
| Minority Interest |
0
|
44
|
39
|
32
|
25
|
20
|
|
| Other Liabilities |
7
|
7
|
8
|
7
|
3
|
6
|
|
| Total Liabilities |
16
N/A
|
85
+432%
|
119
+40%
|
98
-18%
|
69
-29%
|
73
+5%
|
|
| Equity | |||||||
| Common Stock |
0
|
220
|
244
|
244
|
244
|
244
|
|
| Retained Earnings |
71
|
176
|
89
|
6
|
129
|
216
|
|
| Additional Paid In Capital |
109
|
304
|
662
|
662
|
662
|
662
|
|
| Treasury Stock |
0
|
0
|
0
|
29
|
29
|
29
|
|
| Total Equity |
38
N/A
|
700
+1 736%
|
996
+42%
|
883
-11%
|
748
-15%
|
660
-12%
|
|
| Total Liabilities & Equity |
54
N/A
|
785
+1 351%
|
1 115
+42%
|
982
-12%
|
818
-17%
|
734
-10%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
238
|
238
|
244
|
244
|
244
|
244
|
|
Switch to:
Switch to:
See Also
Discover More
